Incomplete septal cirrhosis after high-dose methylprednisolone therapy and regression of liver injury

Liver International

Volumn 35, Issue 2, 2015, Pages 674-676

  Grilli, Elisabetta ^a   Galati, Vincenzo ^a   Petrosillo, Nicola ^a   Del Nonno, Franca ^a   Baiocchini, Andrea ^a  

^a NATIONAL INSTITUTE FOR INFECTIOUS DISEASES L SPALLANZANI   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

METHYLPREDNISOLONE;

ACUTE HEPATITIS; ADULT; ALCOHOL ABUSE; AUTOIMMUNE HEPATITIS; CASE REPORT; CHOLECYSTECTOMY; CORTICOSTEROID THERAPY; DRUG MEGADOSE; FATIGUE; FEMALE; GALLSTONE; HUMAN; INCOMPLETE SEPTAL CIRRHOSIS; JAUNDICE; LETTER; LIVER BIOPSY; LIVER CELL DAMAGE; LIVER CIRRHOSIS; LIVER INJURY; MULTIPLE SCLEROSIS; OPTIC NEURITIS; WEAKNESS; CHEMICALLY INDUCED; COMPLICATION; ECHOGRAPHY; GALLSTONES; INTRAVENOUS DRUG ADMINISTRATION; MULTIPLE SCLEROSIS, RELAPSING-REMITTING; PATHOLOGY; TOXIC HEPATITIS;

ADMINISTRATION, INTRAVENOUS; ADULT; CHOLECYSTECTOMY; DRUG-INDUCED LIVER INJURY; FEMALE; GALLSTONES; HUMANS; LIVER CIRRHOSIS; METHYLPREDNISOLONE; MULTIPLE SCLEROSIS, RELAPSING-REMITTING; OPTIC NEURITIS;

EID: 84921600974     PISSN: 14783223     EISSN: 14783231     Source Type: Journal    
DOI: 10.1111/liv.12607     Document Type: Letter

References (14)

1. Rivero Fernandez M, Riesco JM, Moreira VF, et al. Recurrent acute liver toxicity from intravenous methylprednisolone. Rev Esp Enferm Dig 2008; 100: 720-3.
2. Das D, Graham I, Rose J. Recurrent acute hepatitis in patient receiving pulsed methylprednisolone for multiple sclerosis. Indian J Gastroenterol 2006; 25: 314-6.
3. Furutama D, Kimura F, Shinoda K, et al. Recurrent high-dose intravenous methylprednisolone succinate pulse therapy-induced hepatopathy in a patient with multiple sclerosis. Med Princ Pract 2011; 20: 291-3.
4. Weissel M, Hauff W. Fatal liver failure after high-dose glucocorticoid pulse therapy in a patient with severe thyroid eye disease. Thyroid 2000; 10: 521-3.
5. Takahashi A, Kanno Y, Takahashi Y, et al. Development of autoimmune hepatitis type 1 after pulsed methylprednisolone therapy for multiple sclerosis: a case report. World J Gastroenterol 2008; 14: 5474-7.
6. Hofstee H, Nanayakkara PWB, Stehouwer CDA. Acute hepatitis related to prednisolone. Eur J Internal Med 2005; 16: 209-10.
7. Salvi M, Vannucchi G, Sbrozzi F, et al. Onset of autoimmune hepatitis during intravenous steroid therapy for thyroid-associated ophthalmopathy in a patient with Hashimoto's thyroiditis: case report. Thyroid 2004; 14: 631-4.
8. Loraschi A, Banfi P, Mauri M, et al. Hepatotoxicity after high-dose methylprednisolone for demyelinating disease. Clin Neuropharmacol 2010; 33: 52-4.
9. Gutkowski K, Chwist A, Hartleb M. Liver injury induced by high-dose methylprednisolone therapy: a case report and brief review of the literature. Hepat Mon 2011; 11: 656-61.
10. Popper H. What are the major types of hepatic cirrhosis? In: Ingelfinger F, Relman A, Finland M eds. Controversy in Internal Medicine. Philadelphia: Saunders, 1966; 223-43.
11. Schinoni MI, Andrade Z, de Freitas LA, Oliveira R, Paraná R. Incomplete septal cirrhosis: an enigmatic disease. Liver Int 2004; 24: 452-6.
12. Ishak K, Baptista A, Bianchi L, et al. Histological grading and staging of chronic hepatitis. J Hepatol 1995; 22: 696-9.
13. Rochon J, Protiva P, Seeff LB, et al. Reliability of the Roussel Uclaf Causality Assessment method for assessing causality in drug-induced liver injury, for the Drug-Induced Liver Injury Network (DILIN). Hepatology 2008; 48: 1175-83.
14. Sohrabpour AA, Mohamadnejad M, Malekzadeh R. Review article: the reversibility of cirrhosis. Aliment Pharmacol Ther 2012; 36: 824-32.